Skip to main content

Hykes Andrew's Form 4 filing

Inari Medical, Inc.NARI · filed Jul 3, 2024

Accession no.
0001127602-24-020038
Filed
Jul 3, 2024
Trade date
Jul 1, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions. Open-market sales total $150.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hykes AndrewCIK 0001806431Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2024Common StockSSaleDisposed−3,000$50.08F2−$150,240462,474Direct
Jul 1, 2024Common StockFTax withholdingDisposed−508$50.19−$25,496.52461,966Direct
Jul 1, 2024Common StockFTax withholdingDisposed−947$50.19−$47,529.93461,019Direct
Jul 1, 2024Common StockFTax withholdingDisposed−1,475$50.19−$74,030.25459,544Direct
Jul 1, 2024Common StockFTax withholdingDisposed−1,292$50.19−$64,845.48458,252Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $50.00 to $50.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)